Last Updated : January 25, 2005
Details
FilesGeneric Name:
Atomoxetine hydrochloride
Project Status:
Complete
Therapeutic Area:
Attention deficit hyperactivity disorder
Manufacturer:
Eli Lilly Canada Inc.
Brand Name:
Strattera
Project Line:
Reimbursement Review
Project Number:
SR0031-000
Submission Type:
Initial
Indications:
Attention deficit hyperactivity disorder
Recommendation Type:
Do not list
Final Recommendation:
Recommendation:
Not to list
Files
Last Updated : January 25, 2005